Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing

• Claudia Vollbrecht,

  Affiliations Institute of Pathology, University Hospital Cologne, Cologne, Germany, Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Fabian Dominik Mairinger,

  Affiliation Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

  ⨯
• Ulrike Koitzsch,

  Affiliations Institute of Pathology, University Hospital Cologne, Cologne, Germany, Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Martin Peifer,

  Affiliations Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany, Department of Translational Genomics, Cologne Center of Genomics, University of Cologne, Cologne, Germany

  ⨯
• Katharina Koenig,

  Affiliations Institute of Pathology, University Hospital Cologne, Cologne, Germany, Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Lukas Carl Heukamp,

  Current address: Institute for Hematopathology Hamburg, Hamburg, Germany; New Oncology, Cologne, Germany

  Affiliations Institute of Pathology, University Hospital Cologne, Cologne, Germany, Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany

  ⨯
• Giuliano Crispatzu,

  Affiliations Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany

  ⨯
• Laura Wilden,

  Affiliations Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany

  ⨯
• Karl-Anton Kreuzer,

  Affiliations Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany

  ⨯
• Michael Hallek,

  Affiliations Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany

  ⨯
• Margarete Odenthal ,

  Contributed equally to this work with: Margarete Odenthal, Carmen Diana Herling, Reinhard Buettner

  Affiliations Institute of Pathology, University Hospital Cologne, Cologne, Germany, Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Carmen Diana Herling ,

  Contributed equally to this work with: Margarete Odenthal, Carmen Diana Herling, Reinhard Buettner

  * E-mail: reinhard.buettner@uk-koeln.de (RB); carmen.herling@uk-koeln.de (CDH)

  Affiliations Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany

  ⨯
• Reinhard Buettner

  Contributed equally to this work with: Margarete Odenthal, Carmen Diana Herling, Reinhard Buettner

  * E-mail: reinhard.buettner@uk-koeln.de (RB); carmen.herling@uk-koeln.de (CDH)

  Affiliations Institute of Pathology, University Hospital Cologne, Cologne, Germany, Center for Integrated Oncology (CIO) Cologne-Bonn, University Hospital Cologne, Cologne, Germany, Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯